Research ArticleVaccines

Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans

See allHide authors and affiliations

Science Translational Medicine  04 Nov 2020:
Vol. 12, Issue 568, eabb3611
DOI: 10.1126/scitranslmed.abb3611

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article